SCHEDULE: Vanguard Discloses 7.49% Stake in Hologic Inc.
Ownership Filing
Vanguard Capital Management has reported a beneficial ownership of 7.49% in Hologic Inc. common stock as of March 31, 2026.
Summary
- Vanguard Capital Management, along with its affiliates, now beneficially owns 16,721,923 shares of Hologic Inc. common stock.
- This holding represents 7.49% of the total class of securities.
- Vanguard Capital Management has sole voting power over 2,218,009 shares and sole dispositive power over all 16,721,923 shares.
- The filing indicates that Vanguard funds and other managed accounts have the right to receive dividends and proceeds from the sale of these securities, with no single other person holding more than a 5% interest.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of institutional ownership and does not provide new operational or financial information about Hologic Inc.
Positives
- Significant institutional ownership by a major asset manager like Vanguard can provide stability and confidence to the market.
- Vanguard's reporting of sole dispositive power suggests a clear and consolidated management of these holdings.
Future Outlook
This filing is a disclosure of current ownership and does not contain forward-looking statements or guidance from Hologic Inc.
Industry Context
StockSavvy.ai notes that a Schedule 13G filing by a large institutional investor like Vanguard typically indicates a passive investment strategy, focusing on index tracking or broad portfolio diversification rather than active control or influence over the company's operations. This level of ownership by Vanguard is common across many publicly traded companies.
Stakeholder Impact
- Shareholders: The increased or sustained ownership by a large, stable investor like Vanguard can be viewed positively, potentially indicating confidence in the company's long-term prospects and contributing to share price stability.
- Management: The presence of a significant institutional holder like Vanguard may lead to increased scrutiny and engagement on corporate governance and strategic matters.
Key Dates
| Date | Description |
|---|---|
| 03/31/2026 | Date of Event Which Requires Filing of this Statement |
| 01/12/1998 | SEC Release No. 34-39538 referenced for reporting securities beneficially owned by Vanguard Capital Management LLC and its affiliates. |
| 04/30/2026 | Date of Certification and Signature by Ashley Grim, Head of Global Fund Administration. |
Keywords
Hologic Inc, Vanguard Capital Management, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.